Imunoalergologia Jz s.r.o.
- Address
- Vojtecha Spanyola 43, 010 01 Žilina, Slovakia
Imunoalergologia Jz s.r.o. - Allergy and Immunology Research Center
Imunoalergologia Jz s.r.o. is a specialized clinical research center focused on allergic and immunological disorders. The center demonstrates expertise in conducting complex, multi-center clinical trials investigating novel therapeutic approaches for chronic allergic conditions that significantly impact patients' quality of life.
- Chronic Inducible Urticaria (CINDU) including symptomatic dermographism, cold urticaria, and cholinergic urticaria
- Moderate to severe asthma treatment and propellant safety evaluation
- Novel targeted therapies including BTK inhibitors for urticarial conditions
The research facility specializes in evaluating both efficacy and safety profiles of investigational treatments in patients inadequately controlled by standard antihistamine therapy. Their clinical trial portfolio includes long-term studies with open-label extensions, demonstrating commitment to comprehensive safety monitoring and patient follow-up. The center's expertise extends to comparative studies of inhaled medication delivery systems, including environmentally-conscious propellant formulations for asthma management aligned with Global Initiative for Asthma (GINA) guidelines.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Imunoalergologia Jz s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Remibrutinib in Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines: A Randomized, Double-Blind, Placebo-Controlled Study | Novartis Pharma AG | Phase III | Not Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Beclometasone Dipropionate Anhydrous | 1 | Unknown | 2024-01-15 | 2024-01-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.